Diclofenac Potentiates Sorafenib-Based Treatments of Hepatocellular Carcinoma by Enhancing Oxidative Stress

Diclofenac Potentiates Sorafenib-Based Treatments of Hepatocellular Carcinoma by Enhancing Oxidative Stress

Sorafenib is the first developed systemic treatment for advanced forms of hepatocellular carcinoma, which constitutes the most frequent form of primary liver cancers and is a major global health burden. Although statistically significant, the positive effect of sorafenib on median survival remains m...

Full description

Bibliographic Details
Main Authors: Adrian Paul Duval, Laetitia Troquier, Olga de Souza Silva, Nicolas Demartines, Olivier Dormond
Format: Article
Language:English
Published: MDPI AG 2019-09-01
Series:Cancers
Subjects:
sorafenib
hepatocellular carcinoma
diclofenac
oxidative stress
cell death
co-therapy
Online Access:https://www.mdpi.com/2072-6694/11/10/1453

Internet

https://www.mdpi.com/2072-6694/11/10/1453

Similar Items